Perspective on emerging biomarker-driven therapies in gastric cancer, FGFR2 and beyond

被引：0
|
作者：
Wainberg, Zev A. [1 ]
机构：
[1] UCLA, Ronald Reagan UCLA Med Ctr, Med Ctr, Santa Monica, CA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PSY03-2
引用
收藏
页码：S1355 / S1355
页数：1
相关论文
共 50 条
  • [41] Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing
    Hyung, Sujin
    Han, Boram
    Jung, Jaeyun
    Kim, Seung Tae
    Hong, Jung Yong
    Park, Se Hoon
    Zang, Dae Young
    Park, Joon Oh
    Park, Young Suk
    Kim, Kyoung-Mee
    Kang, Won Ki
    Lee, Jeeyun
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [42] Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer
    Feng, Zhanzhan
    Wang, Shirui
    Yu, Su
    Qu, Can
    Chu, Bingyang
    Qian, Zhiyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
  • [43] Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis
    Kim, Hyeong Su
    Kim, Jung Han
    Jang, Hyun Joo
    Han, Boram
    Zang, Dae Young
    JOURNAL OF CANCER, 2019, 10 (01): : 20 - 27
  • [44] A comprehensive approach to delineate FGFR2 targeted therapy response in diffuse gastric cancer
    Chen, Jiamin
    Lee, Hojoon
    Ji, Hanlee
    CANCER RESEARCH, 2016, 76
  • [45] FGFR2 amplification in serous ovarian cancer
    Tyulyandina, Alexandra
    Tsimafeyeu, Ilya
    Demidova, Irina
    Gikalo, Marina
    Tjulandin, Sergei
    CANCER RESEARCH, 2016, 76
  • [46] Biomarker-driven early lung cancer therapy: the future is now?
    Boeluekbas, Servet
    Eberlein, Michael
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (04) : 764 - 765
  • [47] BIOMARKER-DRIVEN TARGETED ORAL TREATMENT STRATEGY FOR BLADDER CANCER
    Schimmelpfennig, Daley
    Kemper, Michael W.
    Lokeshwar, Soum D.
    Jordan, Andre
    Lokeshwar, Vinata B.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E567 - E568
  • [48] FGFR2 as a molecular target in endometrial cancer
    Byron, Sara A.
    Pollock, Pamela M.
    FUTURE ONCOLOGY, 2009, 5 (01) : 27 - 32
  • [49] Cancer genomics and genetics of FGFR2 (Review)
    Katoh, Masaru
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (02) : 233 - 237
  • [50] Biomarker-driven targeted oral treatment strategy for bladder cancer
    Morera, Daley S.
    Jordan, Andre
    Lokeshwar, Vinata B.
    CANCER RESEARCH, 2017, 77
12345